DXCM
DexCom, Inc. · Healthcare · Medical - Devices
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -11.4% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 360.94K | $29.46M | n/a | −1 |
| Q2 2026 | 168 | +1 | 305.13M | $20.51B | +7 | −5 |
| Q1 2026 | 169 | 0 | 297.37M | $18.71B | +3 | −4 |
| Q4 2025 | 168 | 0 | 314.09M | $20.85B | +1 | n/a |
| Q3 2025 | 26 | +1 | 175.97M | $11.84B | +1 | −1 |
| Q2 2025 | 23 | -1 | 152.74M | $13.33B | n/a | −1 |
| Q1 2025 | 21 | 0 | 61.18M | $4.17B | n/a | n/a |
| Q4 2024 | 21 | +1 | 69.06M | $5.37B | +1 | n/a |
| Q3 2024 | 19 | -2 | 54.56M | $3.66B | n/a | −2 |
| Q2 2024 | 21 | n/a | 52.99M | $6.01B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 16.68M | 0.0% | $1.14B | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Baillie Gifford ✦ | 14.18M | -3.0% | $968.34M | 0.8% | ▼ Trim | 4 | SEC ↗ ×4 |
| 3 | Geode Capital Management ✦ (pasivo) | 10.41M | +4.1% | $708.59M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasivo) | 4.91M | -1.0% | $335.08M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 3.08M | -12.7% | $210.45M | 0.3% | ▼ Trim | 4 | SEC ↗ ×2 |
| 6 | Capital World Investors ✦ | 3.07M | -20.0% | $209.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 2.13M | -50.1% | $145.28M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 8 | T. Rowe Price ✦ | 1.49M | -23.1% | $101.83M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 1.06M | +96.5% | $72.36M | 0.1% | ▲ Add | 4 | SEC ↗ ×4 |
| 10 | Wellington Management ✦ | 723.98K | +2701.7% | $49.44M | 0.0% | ▲ Add | 4 | SEC ↗ ×7 |
| 11 | AQR Capital Management ✦ | 709.03K | +16.6% | $47.36M | 0.0% | ▲ Add | 4 | SEC ↗ ×6 |
| 12 | Renaissance Technologies ✦ | 630.77K | -29.1% | $43.08M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 616.59K | -28.6% | $42.11M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 399.87K | -47.5% | $27.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 386.90K | -75.8% | $26.42M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Millennium Management ✦ | 346.54K | -88.7% | $23.67M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 113.56K | -1.0% | $7.76M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 103.50K | +88.8% | $7.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 71.30K | -27.2% | $4.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 52.00K | 0.0% | $3.55M | 0.0% | Held | 4 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 15.12K | -97.3% | $1.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 15.50K acciones, $973 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 2.56K acc. · $220,975
Director · 6.54K acc. · $549,538
Officer · 1.70K acc. · $142,868
Director · 1.55K acc. · $130,231
Officer · 3.64K acc. · $302,936
Officer · 2.56K acc. · $226,669
Officer, Director · 19.31K acc. · $1.73M
Officer, Director · 97 acc. · $8,867
Officer, Director · 7.35K acc. · $667,332
Officer · 1.70K acc. · $156,281
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología